These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25136636)

  • 1. Potential smoothened inhibitor from traditional Chinese medicine against the disease of diabetes, obesity, and cancer.
    Chen KC; Sun MF; Chen HY; Lee CC; Chen CY
    Biomed Res Int; 2014; 2014():873010. PubMed ID: 25136636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling study on the dynamical structural features of human smoothened receptor and binding mechanism of antagonist LY2940680 by metadynamics simulation and free energy calculation.
    Bai Q; Shen Y; Jin N; Liu H; Yao X
    Biochim Biophys Acta; 2014 Jul; 1840(7):2128-38. PubMed ID: 24637074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cardiovascular disease by traditional Chinese medicine against pregnane X receptor.
    Chen KB; Chen HY; Chen KC; Chen CY
    Biomed Res Int; 2014; 2014():950191. PubMed ID: 25050380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico investigation of potential pyruvate kinase M2 regulators from traditional Chinese medicine against cancers.
    Chen KC; Chen KB; Chen HY; Chen CY
    Biomed Res Int; 2014; 2014():189495. PubMed ID: 25089263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico investigation of potential mTOR inhibitors from traditional Chinese medicine for treatment of Leigh syndrome.
    Chen KC; Lee WY; Chen HY; Chen CY
    Biomed Res Int; 2014; 2014():139492. PubMed ID: 25045657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico investigation of potential TRAF6 inhibitor from traditional Chinese medicine against cancers.
    Chen KC; Lee WY; Chen HY; Chen CY
    Biomed Res Int; 2014; 2014():429486. PubMed ID: 25089269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential mitochondrial isocitrate dehydrogenase R140Q mutant inhibitor from traditional Chinese medicine against cancers.
    Lee WY; Chen KC; Chen HY; Chen CY
    Biomed Res Int; 2014; 2014():364625. PubMed ID: 24995286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor.
    Hoch L; Faure H; Roudaut H; Schoenfelder A; Mann A; Girard N; Bihannic L; Ayrault O; Petricci E; Taddei M; Rognan D; Ruat M
    FASEB J; 2015 May; 29(5):1817-29. PubMed ID: 25636740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of the human smoothened receptor bound to an antitumour agent.
    Wang C; Wu H; Katritch V; Han GW; Huang XP; Liu W; Siu FY; Roth BL; Cherezov V; Stevens RC
    Nature; 2013 May; 497(7449):338-43. PubMed ID: 23636324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.
    Chen KC; Chang SS; Huang HJ; Lin TL; Wu YJ; Chen CY
    J Biomol Struct Dyn; 2012; 30(6):662-83. PubMed ID: 22731403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-based 3D pharmacophore modeling, virtual screening, and molecular dynamic simulation of potential smoothened inhibitors.
    Mohebbi A
    J Mol Model; 2023 Apr; 29(5):143. PubMed ID: 37062794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of potent and novel smoothened antagonists via structure-based virtual screening and biological assays.
    Lu W; Zhang D; Ma H; Tian S; Zheng J; Wang Q; Luo L; Zhang X
    Eur J Med Chem; 2018 Jul; 155():34-48. PubMed ID: 29857275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of silent information regulator 1 (Sirt1) agonists from Traditional Chinese Medicine.
    Chen KC; Jian YR; Sun MF; Chang TT; Lee CC; Chen CY
    J Biomol Struct Dyn; 2013; 31(11):1207-18. PubMed ID: 23075283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triazoles bind the C-terminal domain of SMO: Illustration by docking and molecular dynamics simulations the binding between SMO and triazoles.
    Liu M; Liang G; Zheng H; Zheng N; Ge H; Liu W
    Life Sci; 2019 Jan; 217():222-228. PubMed ID: 30543826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering structural stability and binding mechanisms of potential antagonists with smoothened protein.
    Sinha N; Chowdhury S; Sarkar RR
    J Biomol Struct Dyn; 2018 Aug; 36(11):2917-2937. PubMed ID: 28849750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Modelling of Berberine Derivatives as Inhibitors of Human Smoothened Receptor and Hedgehog Signalling Pathway Using a Newly Developed Algorithm on Anti-Cancer Drugs.
    Kaboli PJ; Bazrafkan M; Ismail P; Ling KH
    Recent Pat Anticancer Drug Discov; 2017 Nov; 12(4):384-400. PubMed ID: 28969581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxysterol binding to the extracellular domain of Smoothened in Hedgehog signaling.
    Nedelcu D; Liu J; Xu Y; Jao C; Salic A
    Nat Chem Biol; 2013 Sep; 9(9):557-64. PubMed ID: 23831757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming the emerging drug resistance of smoothened: an overview of small-molecule SMO antagonists with antiresistance activity.
    Zhang H; Sun Z; Liu Z; Song C
    Future Med Chem; 2018 Dec; 10(24):2855-2875. PubMed ID: 30557039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of potent EGFR inhibitors from TCM Database@Taiwan.
    Yang SC; Chang SS; Chen HY; Chen CY
    PLoS Comput Biol; 2011 Oct; 7(10):e1002189. PubMed ID: 22022246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs.
    Wang C; Wu H; Evron T; Vardy E; Han GW; Huang XP; Hufeisen SJ; Mangano TJ; Urban DJ; Katritch V; Cherezov V; Caron MG; Roth BL; Stevens RC
    Nat Commun; 2014 Jul; 5():4355. PubMed ID: 25008467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.